Upcoming Changes to the Submission of Grant Applications (includes shorter page limits)
December 29, 2009
All new or resubmission applications targeting due dates on or after January 25, 2010 require the use of new application forms and instructions, which include a restructured Research Plan section and shorter page limits. SBIR and STTR applications are limited to a single page for the Specific Aims. Phase I applications are now limited to a maximum of 6 pages for the Research Strategy section. Phase II and Fast Track applications are limited to 12 pages for the Research Strategy section and 12 pages for the Commercialization Plan. Introductions for ALL resubmissions are now limited to one page. Calendar year 2010 SBIR and STTR parent funding opportunity announcements will be released in early to mid-January and will reflect the new format and requirements. For additional information, see Kay Etzler’s December 22, 2009 note (MS Word - 35 KB) to the Small Business Research Community and the Enhancing Peer Review Web site.
REMINDER: SBIR/STTR Submission Date of Dec 5 Falls to Dec 7 Because of the Weekend
November 23, 2009
If a submission date falls on a weekend, it is extended to the following Monday. SBIR and STTR applications submitted to the December 5 submission date will be considered on time if successfully submitted to Grants.gov on or before December 7 and no later than 5:00 p.m. local time of the applicant organization.
SBIR/STTR Programs Extended Through January 31, 2010
November 11, 2009
The House and Senate have not yet completed the SBIR and STTR reauthorizations so the programs have again been extended “as is” for an additional three months through January 31, 2010. This extension affects ten of the eleven agencies (including NIH) participating in SBIR. DoD’s programs were previously extended through September 30, 2010, as part of the National Defense Authorization Act for Fiscal Year 2010.
Congress passes temporary extension for SBA programs, including SBIR/STTR
September 29, 2009
Note: Applicants are encouraged to apply for current funding opportunity announcements available at NIH. After, October 31, 2009, review and funding will be dependent on reauthorization or another extension of the SBIR/STTR programs. However, NIH does not expect any disruption to its regular operations (e.g., review, award timelines). Please be assured that any additional guidance will be provided as NIH receives further information.
On September 25th, Congress passed H.R. 3614, a measure that authorizes the Small Business Administration (SBA) programs through October 31, 2009, providing yet another stopgap extension for the SBIR/STTR programs. Like SBIR/STTR, many SBA programs have been operating under a series of short-term extensions. Although the House and Senate small business committees have been trying to negotiate an SBIR/STTR reauthorization, they have been unable to agree on specific provisions.
Submission Date Extended for 2009-2010 SBIR Commercialization Assistance Program (CAP)
September 16, 2009
The submission date for applications to participate in the NIH SBIR Commercialization Assistance Program has been extended to September 22, 2009. Selected participants will still be notified by September 30, 2009. The CAP offers assistance with business and strategic planning and helps to connect SBIR Phase II awardees with partners, licensees, and/or investors to help move SBIR-developed products into the marketplace. A full description of the program (including eligibility requirements) and application are available at http://grants.nih.gov/grants/funding/cap/index.htm.
NIH Offers Commercialization Assistance Program to SBIR Phase II Awardees
August 27, 2009
NIH announces the availability of a Commercialization Assistance Program (CAP) for its SBIR Phase II awardees from the past six years. Now in its sixth year, this program is designed to help NIH SBIR Phase II awardees transition their SBIR-developed products into the marketplace. The program includes two distinctive tracks that offer customized assistance for both early stage and seasoned companies: Commercialization Training Track and Accelerator Commercialization Track. For details, check the NIH Guide Notice NOT-OD-09-145 and also review the full program description at http://grants.nih.gov/grants/funding/cap/more_on_cap.htm.
NIH/CDC SBIR Contract Solicitation Now Available
August 19, 2009
The PHS 2010-1 SBIR Contract Solicitation is now open. (Receipt date: November 9, 2009. For additional information, see the 08/19/2009 NIH Guide Notice.
NIH Offers SBIR Niche Assessment Program for Phase I SBIR Awardees
July 17, 2009
NIH has contracted with Foresight Science and Technology to perform Technology Niche Analyses (TNA™) for 50 NIH SBIR Phase I awardees. Awardees must have received their Phase I grant/contract in either fiscal year (FY) 2009 or the upcoming FY 2010. For each eligible SBIR Phase I project, the TNA™ will assess potential uses of the technology and then provide a report that addresses the end-user needs, current and emerging competing technologies, the market dynamics, and the technology’s competitive advantage. (NOTE: This program is not available to STTR awardees.) For a full description of the program, check the NIH Guide Notice NOT-OD-09-122 (http://grants1.nih.gov/grants/guide/notice-files/NOT-OD-09-122.html).
NIH Announces Two New ARRA Funding Opportunity Announcements
June 3, 2009
NIH has released two new Funding Opportunity Announcements (FOAs) that may be of interest to the small business research community and will be supported by funds provided to the NIH under the American Recovery & Reinvestment Act of 2009 (“Recovery Act” or “ARRA"). These are:
Application due dates for these FOAs are September 1.
SBIR Program Extended Through July 31, 2009
March 20, 2009
Note: NIH intends to accept SBIR and STTR applications for 2009 due dates that have been announced (e.g., Apr 5, Aug 5, Dec 5). Applicants are encouraged to apply on any of these dates and when their application is ready for submission. For dates after July 31, 2009, review and funding will be dependent on reauthorization or another extension of the SBIR program. However, NIH does not expect any disruption to its regular operations (e.g., review, award timelines). Please be assured that any additional guidance will be provided as NIH receives further information.
House Votes to Reauthorizes Small Business Programs by Kathryn A. Wolfe, CQ Staff
The House Tuesday passed a bill to extend certain expiring small business programs through July 31.
Passed by voice vote, the bill (HR 1541) would reauthorize several Small Business Administration programs set to expire at the end of the week, including the Small Business Innovation Research program, which seeks to involve small high-tech businesses in federal research activities and help commercialize cutting-edge high-tech research.
Nydia M. Velazquez, D-N.Y., chairwoman of the House Small Business Committee, said the extension will give lawmakers time to work on a more extensive overhaul of SBA programs.
“Extending these programs is important but we must not lose sight of a larger goal. Later this Congress we will pass legislation to modernize the SBA and change the agency’s culture. In these difficult economic times we will need an SBA that can respond effectively. This will require extensive reforms,” she said.
David Wu, chairman of the House Science and Technology Subcommittee on Technology and Innovation, said the research program and others need an update.
“Moving forward if we are to continue realizing the full value of SBIR we must authorize them with changes that reflect the evolving innovation environment. It must be an innovation program as well as a jobs and small business program,” Wu said.
He noted that in particular lawmakers must find a way to resolve an issue that, in part, led to problems passing a standalone reauthorization last year: to what extent venture capital-backed high-tech firms should be able to participate in grant awards.
Small businesses not backed by venture capital have argued that allowing them access to grants would crowd out the very startup businesses the grant programs are intended to help flourish.
Beyond SBIR, the extension would reauthorize all SBA programs set to expire at the end of the week, including:
- the Federal and State Technology Partnership Program;
- the SBA’s gift acceptance and co-sponsorship authority;
- the Paul D. Coverdell Drug-Free Workplace Program;
- the HUBZone Program; and
- the National Women’s Business Council.
The Senate passed the measure later that same day without amendment by unanimous consent and referred H.R. 1541 to the White House, where the President signed it into law, P.L. 111-10, on March 19.
NIH Challenge Grants in Health and Science Research (RFA-OD-09-003
) – New Funding Opportunity for Small Businesses (Application due date: April 27, 2009)
March 5, 2009
NIH has received new funds for Fiscal Years 2009 and 2010 as part of the American Recovery & Reinvestment Act of 2009 (Recovery Act), Pub. L. No. 111-5. The NIH has designated at least $200 million in FYs 2009 - 2010 for a new initiative called the NIH Challenge Grants in Health and Science Research. Read More…..
This new program will support research on topic areas that address specific scientific and health research challenges in biomedical and behavioral research that would benefit from significant 2-year jumpstart funds.
The NIH has identified a range of Challenge Areas that focus on specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that would benefit from an influx of funds to quickly advance the area in significant ways. Each NIH Institute, Center, and Office has selected specific Challenge Topics within the broad Challenge Areas (PDF - 1.7 MB) related to its mission. The research in these Challenge Areas should have a high impact in biomedical or behavioral science and/or public health.
NIH anticipates funding 200 or more grants, each of up to $1 million in total costs, pending the number and quality of applications and availability of funds. Additional funds may be available to support additional grants, particularly in the Challenge Area of Comparative Effectiveness Research.
The application due date is April 27, 2009.
REMINDER: SBIR/STTR Submission Date of April 5 Falls to April 6 Because of the Weekend
February 26, 2009
If a submission date falls on a weekend, it is extended to the following Monday. SBIR and STTR applications submitted to the April 5 submission date will be considered on time if successfully submitted to Grants.gov on or before April 6 and no later than 5:00 p.m. local time of the applicant organization.
PHS 2009-2 Omnibus Solicitation for SBIR/STTR Grants Now Available
January 22, 2009
The PHS 2009-2 Omnibus Solicitation of the NIH, CDC, FDA, and ACF for SBIR/STTR Grant Applications and SF 424 (R&R) Application Guide for SBIR/STTR Grant Applications are now available. The solicitation consists of: (1) parent funding opportunity announcement (FOA) for SBIR, (2) a parent FOA for STTR, and (3) narrative descriptions of the programs and research topics (in PDF - 1.70 MB and MS Word - 1.46 MB formats). The due dates for CY 2009 are April 5, August 5, and December 5. AIDS and AIDS-related applications are due May 7, September 7, 2009, and January 7, 2010. Note to Phase II Applicants: See NIH Policy Change on Threshold for Negotiation of Facilities and Administrative (F&A)/Indirect Costs for Phase II SBIR/STTR Grants (NOT-OD-09-038)